Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 9/20 | 0.58 |
| ▸ | NPC1 | O15118 | 6/20 | 0.58 |
| ▸ | RAB9A | P51151 | 6/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.49 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | GAPDH | P04406 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3380631 | 0.90 | ESR2 (0.47) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL9767790 | 0.79 | NPC1 (0.56) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL6254019 | 0.77 | RAB9A (0.58) | NPC1RAB9AKDM4EALDH1A1MAOB | |
| SCHEMBL177366 | 0.74 | RAB9A (1.00) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL30356319 | 0.74 | RAB9A (1.00) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL12304253 | 0.74 | MIF (0.59) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL9368300 | 0.74 | NPC1 (0.68) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL12304339 | 0.74 | MAOB (0.77) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL984946 | 0.74 | NPC1 (0.77) | MIFNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL5008342 | 0.74 | NPC1 (0.68) | MIFNPC1RAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1610954-B1 | METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE | AMERICAN DYE SOURCE INC (CA) | 2010-11-17 | — | — | EP | claimed |
| US-7422649-B2 | Method for recording information in luminescent compositions and uses thereof in articles of manufacture | AMERICAN DYE SOURCE, INC. (CA) | 2008-09-09 | — | — | US | claimed |
| US-20070258912-A1 | Use of Fluorescent Whitening Agents as Antimicrobials | CIBA SPECIALTY CHEMICALS CORP. | 2007-11-08 | — | — | US | claimed |
| EP-1776086-A2 | USE OF FLUORESCENT WHITENING AGENTS AS ANTIMICROBIALS | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-04-25 | — | — | EP | claimed |
| EP-1610954-A4 | METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE | AMERICAN DYE SOURCE INC (CA) | 2006-09-13 | — | — | EP | claimed |
| WO-2006015959-A2 | USE OF FLUORESCENT WHITENING AGENTS AS ANTIMICROBIALS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-16 | — | — | WO | claimed |
| EP-1610954-A1 | METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE | American Dye Source, Inc. (CA) | 2006-01-04 | — | — | EP | claimed |
| US-20050103424-A1 | Method for recording information in luminescent compositions and uses thereof in articles of manufacture | AMERICAN DYE SOURCE, INC. (CA) | 2005-05-19 | — | — | US | claimed |
| WO-2005025882-A1 | METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE | AMERICAN DYE SOURCE, INC. (CA) | 2005-03-24 | — | — | WO | claimed |
| EP-4461775-A1 | INKJET INK | Kishu Giken Kogyo Co., Ltd. (JP) | 2024-11-13 | — | — | EP | disclosed |
| US-11986997-B2 | Three-dimensional printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20210402684-A1 | THREE-DIMENSIONAL PRINTING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-12-30 | — | — | US | disclosed |
| WO-2020251532-A1 | THREE-DIMENSIONAL PRINTING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-12-17 | — | — | WO | disclosed |
| EP-1610954-B1 | METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE | AMERICAN DYE SOURCE INC (CA) | 2010-11-17 | — | — | EP | disclosed |
| EP-0946660-A1 | A JET INK COMPOSITION | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1999-10-06 | — | — | EP | disclosed |
| US-5939468-A | A JET INK FOR PRODUCING MARKS ON AN OBJECT ARE INVISIBLE TO UNAIDED EYE AND ARE VISIBLE WHEN EXCITED BY A ACTIVATION RADIATION COMPRISES A SOLVENT, FLUOROSCENT DYE, AN ACRYLIC ACID-STYRENE COPOLYMER BINDER, SULFONAMIDE RESIN, PLASTICIZER | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0914391-A1 | A JET INK COMPOSITION | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998027170-A1 | A JET INK COMPOSITION | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1998-06-25 | — | — | WO | disclosed |
| US-5755860-A | INK CARRIER, FLUORESCENT COLORANT, CELLULOSIC BINDER, AND A TETRAALKYL-AMMONIUM OR PHOSPHONIUM SALT; BLUSH, BLEED AND FADE RESISTANCE | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1998004640-A1 | A JET INK COMPOSITION | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1998-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258912-A1 | Use of Fluorescent Whitening Agents as Antimicrobials | CUTA, CAT, LPO | MIF 3348/4885NPC1 3273/4885RAB9A 3707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.